Thursday November 26 2009 | Biotechnology feed | All feeds
|
|
S.L.A. Pharma AG
Download detailed PDF Members: S.L.A. Pharma AG acquires pharmaceutical developments at an early stage from inventors (generally medical doctors). We then invest in patent and trademark protection, R&D and registration applications. Thereafter, S.L.A. Pharma AG seeks to license the marketing rights to larger pharmaceutical companies to carry out full-scale manufacturing and commercialisation. We have completed various licensing agreements with companies based in the USA, Japan and Europe.David and Justin Slagel established the Swiss company, S.L.A. Pharma AG, and its UK service operation, S.L.A. Pharma AG UK Ltd, in 1997. David Slagel was previously the owner and President of Tillotts Laboratories Ltd (UK) and Tillotts Pharma AG (Switzerland), both of which were successful niche pharmaceutical companies specialising in gastroenterology and cardiology
This page has been viewed 523 times since April 2007, the link to the organisation's website has been followed 100 times Recent Search Terms used to find this page: sla pharma | justin slagel sla pharma | sla pharma tillotts | S.L.A-PHARMA AG | S.L.A. Pharma | S.L.A. Pharma | justin slagel SLA | tillotts pharma AG drug patents | tillotts pharma AG drug patents | s.l.a. pharma | . Search for more companies in Postfach Search for more companies in Liestal This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for S.L.A. Pharma AG | ||||||||||||||||||||||||||||||||
|